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Studies on the Natural History of Asymptomatic 
Diabetes in Young People 
By Stefan S. Fajans, John C. Floyd, Sumer Pek. and Jerome W. Corm 
Forty-five young patients with chem- 
ical diabetes have been followed for 
1-16 yr. Among 21 of them aged 9-17 
yr, 4 have developed insulin-dependent 
diabetes mellitus. None of the 24 aged 
18-25 yr have decompensated. De- 
layed and subnormal insulin response 
to oral glucose was noted in those with 
chemical diabetes compared to nor- 
mals, except for one nonobese patient 
who had hyperinsulinemia. Consider- 
able fluctuation in glucose and/or in- 
sulin responses and their relationship 
was noted in repeated testing. These 
observations emphasize that validation 
of diagnostic criteria for glucose tol- 
erance test interpretation need not 
depend on a high rate of progression 
to more severe hyperglycemia, and 
that the slow progression of latent 
diabetes permits consideration of pro- 
phylactic measures. 
I T IS WELL RECOGNIZED that the carbohydrate intolerance of latent or chemical diabetes in middle age may show little or no progression in 
severity over many years. On the other hand, it has generally been assumed 
that diabetes in children and adolescents can rarely be recognized at an early 
stage, since the first symptoms of overt diabetes are frequently of sudden and 
exposive onset.’ It has also been reported that the course of diabetes in the 
young is characterized by a rapid and progressive decrease in insulin reserves.2 
Since 1960, we have reported that asymptomatic, latent, or “chemical” diabetes 
can be recognized in children and young adults by the finding of abnormal 
carbohydrate tolerance, and that such patients may exhibit the nonprogressive 
course of the carbohydrate intolerance of “maturity onset-type” of diabetes.3-7 
Since 1966, at least eight other reports have appeared, which also indicate 
that asymptomatic diabetes can be discovered in young people by the use of 
the glucose tolerance test.*-l5 
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Table 1. Mild Diabetes of Young People 
_~ 
Patients Patients Control Subjects 
Age 9-17 Age 18-25 Age 18-25 
Number of subjects 
Mean age 
FBS <99 mg/lOO ml 
FBS 100-120 mg/lOO ml 
FBS >120 mg% 
Blood glucose-sum of 
increments mg/lOO ml 




Yr of follow-up 
Mean 
Progression to insulin- 
dependent diabetes 
Age at diagnosis 
Initial FBS 
Time interval from initial 
diagnosis 
21 24 48 
12.9 22.1 21.6 
13* 16* 48 
5t 5 0 
3 3 0 
619e-53 521 t38 130’10 
167231 (14) 
3 









4 0 0 
11 yr, 14yr, 11 yr, 17yr 
125 mg/lOO ml, 99 mg/lOO ml 
106 mg/lOO ml, 77 mg/lOO ml 
3 mo, 4’12 mo, 2 yr, 2 yr 
*Transient fasting hyperglycemia (>120 mg/lOO ml) subsequently in four patients, FBS 
100-120 mg/lOO ml in one additional patient. 
tTransient fasting hyperglycemia (>120 mg/lOO ml) subsequently in one patient. 
*Transient fasting hyperglycemia (>120 mg/lOO ml) subsequently in two patients. 
We wish to report upon levels of blood glucose (venous whole blood) and 
plasma insulin obtained during glucose tolerance tests on 45 children, adoles- 
cents, and young adults in whom a diagnosis of latent diabetes was made. 
Follow-up observations over periods of l-16 yr have been made in 35 of 
these individuals. These results extend observations reported previously.697 
These 4.5 patients have been divided arbitrarily into two groups, one 
consisting of 21 patients aged 9-17, and the other of 24 patients aged 18-25 
yr (Table 1). All have had one or more abnormal glucose tolerance tests by 
our criteria,5 and all but two by the USPHS criteria.16 Thirteen of the 45 pa- 
tients have had fasting hyperglycemia (FBS > 120 mg/lOO ml) at least inter- 
mittently, and another 11 had fasting blood sugar levels between 100-120 mg/ 
100 ml (Table 1). The mean sums of increments in blood glucose over control 
levels for all six intervals of the glucose tolerance tests for the two groups 
were 619 * 53 and 521 2 38 mg/lOO ml, respectively (Table 1). In 48 healthy 
control subjects aged 18-25 yr, the corresponding mean sum of blood gIucose 
increments was 130 -C 10 mg/lOO ml, which is significantly less than those 
of the two groups of patients (p <O.OOl). In nonobese patients, the sums of 
increments in plasma insulin over control levels for all six intervals of the 
glucose tolerance tests were 167 2 31 &I/ml for the 14 younger patients, 
214 f 34 $J/ml for 13 of the older patients, both significantly less (p <0.002 
and <O.OZ, respectively) than the 467 2 47 $J/ml for the control subjects 
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who also were nonobese (Table 1). One nonobese, 1%yr-old patient had an 
insulin response of 1175 JJ/ml. His sum of increments in blood glucose was 
558 mg/loo ml. Obesity was present in three of the younger and five of the 
older patients. A strong family history of diabetes was present in 20 of the 
younger and 22 of the older groups of patients. 
Patients in the two groups have had follow-up tests performed during 
periods of up to 16 and 13 yr, respectively (Table 1). Four patients in the 
younger group have progressed to insulin-dependent diabetes. The ages at 
diagnosis were II, 14, 11, and 17 yr, and the initial fasting blood sugar levels 
were 125, 99, 106, and 77 mg/lOO ml, respectively. The initial glucose toler- 
ance tests of these four patients did not differ significantly from the mean of 
the whole group. The time interval between the diagnosis of asymptomatic 
diabetes and progression to insulin-dependent diabetes was 3 mo, 4’/2 mo, 
2 yr, and 2 yr, respectively. The 35 patients who have had more than 1 yr of 
followup have been treated either with diet alone or additionally with a sul- 
fonylurea. It is not the purpose of this report to evaluate the effectiveness of 
therapy. 
In the diabetic patients aged 9-17 yr, both the fasting and the postglucose 
tolerance tests were significantly higher than in the control subjects aged 
18-25 yr (Fig. 1). 
Plasma levels of insulin for 14 of the nonobese patients of this group are 
shown in Fig. 1. The plasma levels of insulin in the fasting state were not 
different from the control group. After the administration of glucose, the 
diabetic group exhibited a significantly delayed and subnormal increase in 
plasma insulin. These results reflect determinations of plasma insulin assayed 
on glucose tolerance tests performed after 1961, when an immunoassay for 
insulin was available to us. In 5 of the 14 patients, plasma levels of insulin 
were not determined on the earher gIucose tolerance tests (prior to 1962) 
included in the mean blood glucose results of Fig. 1. However, mean levels 
of blood glucose during the 14 glucose tolerance tests on which these initial 
measurements of plasma insulin were made were almost identical to those of 
the levels of the whole group shown in Fig. 1. 
‘._.‘. Diabetic Patients, Age 9-/7(mron 12.7)~mn 
- tfbotthy Subpcts, Age I8-2Sfmeon 2151 yews 
( )=Number of Subjects 
BLOOD GLUCOSE 
Fig. 1. Initial diagnostic 
standard glucose toler- 
ance tests (1.75 g glu- 
cosel kg ideal body 
weight) in mildly diabetic 
patients ages 9-17 at 
diagnosis, and glucose 
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...‘..........’ Diobstic Patmnts, Age M-25 I man 22.2 I Years 
- Healthy Subjects, Ago t8-25( mm 2/. 5 I Years 
( 1 =N 
25Or BLOOD GLUCOSE 250 
Fig. 2. Initial diagnos- 
tic standard glucose tol- 
erance tests (1.75 g 
glucose/kg ideal body 
weight) in mildly diabetic 
patients ages 18-25 at 
diagnosis, and glucose 
tolerance tests in healthy 
control subjects. 
Age 01 Dlognosas 9 - 17 (mean I2 6) years 
- Inh,l GTT ------ fnrhd lnsulrn Level wth GTT 
--c-- GTT After l-/5.6(6 4Jyrs - ,nw,m Lmh After l-8.4(3.9) yrs 
25D BLOOD GLUCOSE 
r T _ 
2oo_ PLASMA INSULIN 
Fig. 3. Initial and last 
follow-up glucose toler- 
ance tests in mildly dia- 
betic patients, ages 9-17 
at diagnosis. 
Aqe 01 Diagnom : 18 -25 L m&m 22.3)Yeaon 
- tatid GTT - Imtrol lnsulrn Low/s with GTT 









Fig. 4. Initial and last 
follow-up glucose toler- 
ance tests in mildly dia- 
betic patients, ages 18- 
25 at diagnosis. 
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The mean results of the initial diagnostic glucose tolerance tests performed 
in the patients aged 18-25 yr are shown in Fig. 2. Maximal increases in blood 
glucose were similar to those of the younger patients, but the subsequent 
decreases in blood glucose occurred somewhat faster. In 13 nonobese patients, 
there was a delayed and subnormal increase in plasma insulin after admin- 
istration of glucose similar to that of the younger patients. In three of these 
patients, these determinations were not made on the earlier glucose tolerance 
tests included in the mean blood glucose results of Fig. 2. One nonobese 
patient showed a response, which, although delayed in reaching its peak, 
showed no delay at l/2 hr and was quantitatively greater than the responses of 
all but one of the control subjects (Fig. 2). These excessive levels of plasma 
insulin as measured by total immunoreactive insulin in peripheral blood were 
shown by Dr. Donald Steiner not to be due to proinsulin. The patient has 
normal sensitivity to exogenous insulin as determined by a standard insulin 
tolerance test. These data do not provide an explanation for the abnormal 
carbohydrate tolerance manifested by this patient. 
In 4 of the 21 patients aged o-17 yr at diagnosis, carbohydrate tolerance 
deteriorated to insulin-dependent diabetes. The other 17 patients have had 
follow-up tests for periods of 1-15.8. Although the abnormality in glucose 
tolerance has definitely progressed in two of these patients, the mean glucose 
tolerance of this group shows no evidence of decompensation but does show 
significant impro.lement (Fig. 3). The mean plasma insulin response during 
glucose tolerance tests performed l-8.4 yr after the one on which the initial 
insulin determinations were made are subnormal and have shown no evidence 
of deterioration (Fig. 3). 
Similar follow-up results were obtained for the older patients who have 
been retested at intervals for periods of 1-13 yr (Fig. 4). The mean results 
indicate that no significant change in glucose tolerance has occurred. There 
is no evidence of significant change in the subnormal insulin response to 
glucose after intervals of l-8*/2 yr. 
Considerable fluctuation in glucose tolerance may occur in some patients 
when the test is repeated at intervals of days, months, or years, whether such 
patients are untreated or treated with diet or tolbutamide. Similar fluctuations 
may occur in the insulin response to glucose. Although for groups of diabetic 
patients the magnitude of the mean insulin response to glucose is inversely 
related to the degree of glucose intolerance, on repetitive tests in the same 
patient there may be no consistent relationship between glucose tolerance and 
the accompanying plasma insulin response as measured by levels of insulin in 
peripheral blood by conventional radioimmunoassay.6*7 On repeated tests, 
there may be (1) the expected relationship between changes in glucose toler- 
ance and the associated insulin response; (2) glucose tolerance may vary 
while the insulin response is unchanged; or (3) the insulin response may 
vary while glucose tolerance remains constant. Some representative examples 
of these findings have been reported previously.6*7 Two further illustrations 
of these findings are shown in. Figs. 5 and 6. 
Patient S.N., an ll-yr-old male, is a sibling of a girl who has ketotic-type 
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Fig. 5. Glucose toler- 
ance tests in male patient 
S.N. (born 1 /I /58). 
diabetes and the offspring of a father with latent diabetes, which had been 
discovered by the performance of a routine glucose tolerance test. The boy had 
an abnormal cortisone glucose tolerance test in June 1969, but a normal 
standard glucose tolerance test in July 1969, associated with subnormal levels 
of plasma insulin (Fig. 5). At that time, he would have been classified as being 
a subclinical diabetic. In December 1969 and January 1970, asymptomatic or 
latent diabetes was apparent with mild fasting hyperglycemia of 125 mg/ 
100 ml. The abnormal glucose tolerance test in December 1969 was associated 
with as rapid and somewhat greater increases in plasma insulin after glucose 
ingestion than when his glucose tolerance test was normal. However, in 
January 1970, greater glucose intolerance was associated with a delayed and 
lower insulin response (Fig. 5). Diet and tolbutamide therapy were then 
initiated. In February 1970, a 2-hr postbreakfast blood sugar level was 116 
mg/lOO ml. In March 1970, overt diabetes was present with a fasting blood 
sugar level of 259 mg/lOO ml and a history of polydipsia and nocturia during 
- 4/2?/67 5’ 9” 127 
. . . . . . ../1/21/68 5’lO” 147 
---- Il/22h38 5’10” 147 
Fig. 6. Glucose toler- 
ance tests in male patient 
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the last 5 days. At this time, there was only a negligible increment in plasma 
insulin in response to the administration of glucose (Fig. 5). 
Patient S.J., a male whose family history of diabetes mellitus included his 
mother and brother, had normal glucose tolerance in April 1967 when he was 
17 yr old (Fig. 6). One and one-half yr later, two grossly abnormal glucose 
tolerance tests were associated with a more rapid insulin response on one 
occasion and a delayed one on another occasion. However, plasma levels of 
insulin were higher at each time period during these two tests than 1% yr 
earlier when he maintained normal glucose tolerance (Fig. 6). These levels of 
plasma insulin are lower than those of the mean of the control subjects. 
SUMMARY 
The results of these studies have led us to the following conclusions. 
(1) Although asymptomatic diabetes may progress to overt diabetes in some 
children, adolescents, and young adults, in the majority of such individuals 
studied glucose intolerance does not increase in severity over periods of up 
to 16 yr. (2) In the majority of these patients the mean insulin responses to 
glucose are delayed and subnormal, but the insulin response may not deteri- 
orate over periods of up to 8 yr. (3) In individual patients there may be no 
consistent relationship between glucose tolerance and the insulin response 
to glucose as measured by plasma levels of insulin in peripheral blood by 
conventional radioimmunoassay. With the assumptions that (a) the fractional 
removal rate of insulin from plasma or (b) the concentrations of proinsulin 
or connecting peptide in plasma during glucose tolerance tests do not differ 
from one test to another in any one individual, our findings suggest that factors 
in addition to the abnormal pancreatic insulin response to glucose may deter- 
mine normality or abnormality of glucose tolerance. A normal glucose toler- 
ance test may occur in some diabetic patients in the presence of a greatly 
delayed and subnormal insulin response. This may occur either before or 
after the initial recognition of the disease. Similar findings have been reported 
also in prediabetic subjects17-20 and in other nondiabetic relatives of diabetic 
patients. 21-23 (4) Since a large majority of the patients in this study have 
shown no significant progression of the disease, validation of diagnostic criteria 
for the interpretation of the glucose tolerance test need not depend on a high 
rate of progression to more severe hyperglycemia. (5) The slow progression 
of latent diabetes in many children and adolescents suggests that with early 
detection, time may be available for the institution of prophylactic procedures 
that have the potentiality of being effective. 
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Discussion 
Dr. Gufhrie: I am a little concerned about the norms that you showed for insulin. 
These were older patients. Just looking at a few of the figures-your 30-min value, for 
instance, was around 100 ~Ulml-then you compared the children to this. By our norms 
in children the means are much lower than that. Our means at 30 min, for instance, are 
